PMN · Categories · Form 4

PMN - SEC Form 4 insider transactions

ProMIS Neurosciences Inc. (PMN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PMN

• 57d
  SEC Form 4 filed by Director Wyman William W

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Director Williams Eugene

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Chief Executive Officer Warma Neil K

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Director Shafmaster Madge K.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Chief Scientific Officer Cashman Neil

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Principal Accounting Officer Milbury Max A.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Director Mandel-Brehm Josh

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Chief Development Officer Kaplan Johanne

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 57d
  SEC Form 4 filed by Director Alex Slanix Paul

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 162d
  Chief Scientific Officer Cashman Neil was granted 4,122 shares (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 162d
  Chief Development Officer Kaplan Johanne was granted 2,060 shares, increasing direct ownership by 817% to 2,312 units (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 162d
  Chief Executive Officer Warma Neil K was granted 6,183 shares (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 162d
  Principal Accounting Officer Milbury Max A. was granted 6,595 shares, increasing direct ownership by 364% to 8,409 units (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 162d
  Director Kirwin Patrick D. was granted 3,050 shares, increasing direct ownership by 146% to 5,135 units (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 267d
  SEC Form 4 filed by Large owner Abg Management Ltd.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 291d
  Large owner Jeremy M. Sclar 2012 Irrevocable Family Trust converted options into 2,093,022 shares, increasing direct ownership by 129% to 3,710,459 units (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 297d
  SEC Form 4 filed by Chief Executive Officer Warma Neil K

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 297d
  SEC Form 4 filed by Principal Accounting Officer Milbury Max A.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 297d
  SEC Form 4 filed by Chief Development Officer Kaplan Johanne

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 297d
  SEC Form 4 filed by Chief Medical Officer Altstiel Larry Douglas

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 297d
  SEC Form 4 filed by Chief Scientific Officer Cashman Neil

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 313d
  Large owner Sclar Jeremy M. converted options into 2,093,022 shares (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 338d
  Amendment: SEC Form 4 filed by Title 19 Promis

  4/A - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 338d
  Amendment: SEC Form 4 filed by Gordon Michael S

  4/A - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 338d
  Gordon Michael S disposed of 48,333 shares (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 353d
  Large owner Gordon Michael S converted options into 359,400 shares (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 353d
  Large owner Title 19 Promis converted options into 359,400 shares, increasing direct ownership by 17% to 2,435,029 units (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 381d
  Large owner Gordon Michael S sold 93,223 shares, closing all direct ownership in the company (SEC Form 4)

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 397d
  SEC Form 4 filed by Director Mandel-Brehm Josh

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 397d
  SEC Form 4 filed by Director Kirwin Patrick D.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 397d
  SEC Form 4 filed by Director Shafmaster Madge K.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 397d
  SEC Form 4 filed by Director Wyman William W

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 397d
  SEC Form 4 filed by Director Williams Eugene

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 604d
  SEC Form 4 filed by Principal Accounting Officer Milbury Max A.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 604d
  SEC Form 4 filed by Chief Development Officer Kaplan Johanne

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 604d
  SEC Form 4 filed by Chief Scientific Officer Cashman Neil

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 604d
  SEC Form 4 filed by Chief Medical Officer Altstiel Larry Douglas

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 646d
  SEC Form 4 filed by Chief Executive Officer Warma Neil K

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 648d
  SEC Form 4 filed by Director Wyman William W

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 648d
  SEC Form 4 filed by Director Williams Eugene

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 648d
  SEC Form 4 filed by Director Shafmaster Madge K.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 648d
  SEC Form 4 filed by Director Mandel-Brehm Josh

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 648d
  SEC Form 4 filed by Director Kirwin Patrick D.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 925d
  SEC Form 4 filed by Warma Neil K

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 928d
  SEC Form 4 filed by Sclar Jeremy M.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 991d
  SEC Form 4 filed by Malenfant Gavin T.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 991d
  SEC Form 4 filed by Kaplan Johanne

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 991d
  SEC Form 4 filed by Altstiel Larry Douglas

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 991d
  SEC Form 4 filed by Milbury Max A.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 991d
  SEC Form 4 filed by Cashman Neil

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 991d
  SEC Form 4 filed by Geffken Daniel E.

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 1058d
  SEC Form 4: Farfel Gail M was granted 53,192 shares, increasing direct ownership by 2,660% to 55,192 units

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 1058d
  SEC Form 4: Kirwin Patrick D. was granted 11,000 shares, increasing direct ownership by 26% to 52,983 units

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 1058d
  SEC Form 4: Malenfant Gavin T. was granted 2,660 shares

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 1058d
  SEC Form 4: Cashman Neil was granted 10,643 shares, increasing direct ownership by 10% to 113,304 units

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)
• 1058d
  SEC Form 4: Milbury Max A. was granted 13,297 shares, increasing direct ownership by 782% to 14,997 units

  4 - ProMIS Neurosciences Inc. (0001374339) (Issuer)

Other PMN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends